Louis H. Morrone sold $643k of ABT
EXECUTIVE VICE PRESIDENT at ABBOTT LABORATORIES. 5,850 shares at an average of $109.83, traded Aug 11, 2026, filed Aug 13, 2026.
Score components
- +15RoleOfficer
- +20Trade size$643k at market
- 0Share of holdings soldSold 7.6% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001867666-26-000013, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | SOpen-market sale Common shares without par value | -5,850 | $109.83 | $643k | 70,724 | Aug 13, 2026 |
| Aug 12, 2026 | IDiscretionary transaction Common shares without par valueindirect: Profit Sharing Trust | -12 | $107.99 | $1,296 | 0 | Aug 13, 2026 |
Related signals
Other insiders at ABBOTT LABORATORIES and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | ABBOTT LABORATORIES | John A. McCoy Jr. VICE PRESIDENT AND CONTROLLER | $2,958 27 shares | -0% | |
| 70Notable | ABBOTT LABORATORIES | Robert B Ford CHAIRMAN AND CEO | $46M 398,832 shares | -57% | |
| 62Notable | ABBOTT LABORATORIES | John G Stratton director | $174k 2,000 shares | +9% | |
| 72Notable | ABBOTT LABORATORIES | Daniel J Starks director | $927k 10,000 shares | +0% | |
| 75Notable | ABBOTT LABORATORIES | Philip P Boudreau EVP AND CFO | $201k 2,200 shares | - | |
| 40Moderate | ABBOTT LABORATORIES | Daniel Gesua Sive Salvadori EVP AND GROUP PRESIDENT | $102k 885 shares | -1% | |
| 48Moderate | ABBOTT LABORATORIES | John A. McCoy Jr. VICE PRESIDENT AND CONTROLLER | $68k 585 shares | -2% | |
| 48Moderate | ABBOTT LABORATORIES | Mary K Moreland EXECUTIVE VICE PRESIDENT | $71k 613 shares | -1% | |
| 51Moderate | ABBOTT LABORATORIES | Louis H. Morrone EXECUTIVE VICE PRESIDENT | $132k 1,144 shares | -1% | |
| 39Weak | ABBOTT LABORATORIES | Eric Shroff Senior Vice President | $82k 709 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.